Randomized Controlled Trial
Copyright ©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1734-1741
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1734
Figure 3
Figure 3 Comparison of LogMAR best-corrected visual acuity between the two groups before and after treatment. A: LogMAR best-corrected visual acuity; B: Central macular thickness. There was no significant difference between the multi-point group and the single-point group before treatment (P > 0.05), and the multi-point group was lower than the single-point group 1 month after treatment (P < 0.05), and there was no significant difference between the multi-point group and the single-point group 6 months and 12 months after treatment (P > 0.05). aP < 0.05. CMT: Central macular thickness.